Viewing StudyNCT06416410

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-19 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06416410
Status: RECRUITING
Last Update Posted: 2024-05-20
First Post: 2024-05-09
Brief Title: JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS pG12C Mutation
Sponsor: Jacobio Pharmaceuticals Co Ltd
Organization: Jacobio Pharmaceuticals Co Ltd
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Non-squamous Non Small Cell Lung Cancer
Advanced Non-squamous Non-small-cell Lung Cancer
Keywords: